Scheffoleoside ACAS# 160669-23-8 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 160669-23-8 | SDF | Download SDF |
PubChem ID | 163011899.0 | Appearance | Powder |
Formula | C48H78O19 | M.Wt | 959.13 |
Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | [6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl] 10,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate | ||
SMILES | CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OCC3C(C(C(C(O3)OC(=O)C45CCC(CC4C6=CCC7C(C6(CC5)C)(CCC8C7(CC(C(C8(C)CO)O)O)C)C)(C)C)O)O)O)CO)O)O)O | ||
Standard InChIKey | LGOPJRNHNGETGG-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C48H78O19/c1-21-29(52)31(54)34(57)40(63-21)66-37-25(18-49)64-39(36(59)33(37)56)62-19-26-30(53)32(55)35(58)41(65-26)67-42(61)48-14-12-43(2,3)16-23(48)22-8-9-28-44(4)17-24(51)38(60)45(5,20-50)27(44)10-11-47(28,7)46(22,6)13-15-48/h8,21,23-41,49-60H,9-20H2,1-7H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Scheffoleoside A Dilution Calculator
Scheffoleoside A Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.0426 mL | 5.2131 mL | 10.4261 mL | 20.8522 mL | 26.0653 mL |
5 mM | 0.2085 mL | 1.0426 mL | 2.0852 mL | 4.1704 mL | 5.2131 mL |
10 mM | 0.1043 mL | 0.5213 mL | 1.0426 mL | 2.0852 mL | 2.6065 mL |
50 mM | 0.0209 mL | 0.1043 mL | 0.2085 mL | 0.417 mL | 0.5213 mL |
100 mM | 0.0104 mL | 0.0521 mL | 0.1043 mL | 0.2085 mL | 0.2607 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 3-epi-Bufalin
Catalog No.:BCX1267
CAS No.:465-20-3
- Araloside C
Catalog No.:BCX1266
CAS No.:55446-15-6
- Dihydrolanosterol
Catalog No.:BCX1265
CAS No.:911660-54-3
- Tarasaponin IV
Catalog No.:BCX1264
CAS No.:156980-31-3
- Fallacinol
Catalog No.:BCX1263
CAS No.:569-05-1
- Isoasiaticoside
Catalog No.:BCX1262
CAS No.:948827-09-6
- Tenacissoside A
Catalog No.:BCX1261
CAS No.:107352-30-7
- cis-Pellitorine
Catalog No.:BCX1260
CAS No.:639086-18-3
- Brevicornin
Catalog No.:BCX1259
CAS No.:173792-49-9
- Stipuleanoside R2
Catalog No.:BCX1258
CAS No.:96627-72-4
- Tibesaikosaponin V
Catalog No.:BCX1257
CAS No.:2319668-87-4
- Tenaxin I
Catalog No.:BCX1256
CAS No.:86926-52-5
- Demethyldaphnoretin-7-O-glucoside
Catalog No.:BCX1269
CAS No.:438578-91-7
- Protoanemonin
Catalog No.:BCX1270
CAS No.:108-28-1
- Sinomenine N-oxide
Catalog No.:BCX1271
CAS No.:1000026-77-6
- 6-Hydroxyluteolin
Catalog No.:BCX1272
CAS No.:18003-33-3
- Phenoxodiol
Catalog No.:BCX1273
CAS No.:81267-65-4
- 2'-O-Methylphloretin
Catalog No.:BCX1274
CAS No.:111316-17-7
- 2',4,4',6'-Tetramethoxychalcone
Catalog No.:BCX1275
CAS No.:94103-36-3
- Hispidol
Catalog No.:BCX1276
CAS No.:5786-54-9
- N-Acetylcytisine
Catalog No.:BCX1277
CAS No.:6018-52-6
- Palvanil
Catalog No.:BCX1278
CAS No.:69693-13-6
- Micromarin F
Catalog No.:BCX1279
CAS No.:73292-93-0
- 3,5,7-Trimethoxyflavone
Catalog No.:BCX1280
CAS No.:26964-29-4
Oleanane- and Ursane-Type Triterpene Saponins from Centella asiatica Exhibit Neuroprotective Effects.[Pubmed:32502339]
J Agric Food Chem. 2020 Jul 1;68(26):6977-6986.
Six new pentacyclic triterpenoid saponins, centelloside F (1), centelloside G (2), 11-oxo-asiaticoside B (3), 11-oxo-madecassoside (4), 11(beta)-methoxy asiaticoside B (5), and 11(beta)-methoxy madecassoside (6), along with seven known ones, asiaticoside (7), asiaticoside B (8), madecassoside (9), centellasaponin A (10), isoasiaticoside (11), Scheffoleoside A (12), and centelloside E (13), were separated from the 80% MeOH extract of the whole plant of Centella asiatica, which has been used as a medicinal plant and is now commercially available as a diatery supplement in many countries. Compounds 1 and 2, 3 and 4, and 5 and 6 are three pairs of isomers with oleanane- or ursane-type triterpenes as aglycones. The chemical structures of the new triterpene saponins were fully characterized by extensive analysis of their nuclear magnetic resonance and high-resolution electrospray ionization mass spectrometry data. The protective effects of compounds 1-13 on PC12 cells induced by 6-OHDA were screened, and compound 3 displayed the best neuroprotective effect, with 91.75% cell viability at the concentration of 100 muM. Moreover, compound 3 also attenuated cell apoptosis and increased the mRNA expression of antioxidant enzymes, including superoxide dismutase and catalase. Additionally, compound 3 activated the phosphatidylinositol 3-kinase/Akt pathway, including PDK1, Akt, and GSK-3beta. These findings suggested that triterpene saponins from C. asiatica were worthy of further biological research to develop new neuroprotective agents.
Validated UHPLC-MS/MS method for simultaneous determination of four triterpene saponins from Akebia trifoliata extract in rat plasma and its application to a pharmacokinetic study.[Pubmed:31099065]
Biomed Chromatogr. 2019 Oct;33(10):e4585.
Saponin PH, akemisaponins E, saponin PJ(1) and Scheffoleoside A, the main bioactive triterpene saponins of Chinese traditional medicine Akebia trifoliata, contribute to its diuretic pharmacological activity. Because of interactions of the multiple ingredients in vivo, pharmacokinetic studies of multiple triterpenes after administration of A. trifoliata extract are essential to clarify their pharmacological effects. The purpose of this study was to develop an efficient and sensitive UHPLC-MS/MS method for simultaneous determination of these four triterpene saponins in rat plasma. The biosamples were prepared by liquid-liquid extraction with n-butanol. The chromatographic separation was performed on a Phenomenex Luna((R)) C(18) (150 x 2 mm, 3 mum) with a mobile phase consisting of acetonitrile and water at a flow rate of 0.5 mL/min. The MS/MS system was operated in a negative multiple reaction monitoring mode, and the precursor-product ion transitions were optimized as m/z 941.6 --> 471.1 for saponin PH, 941.7 --> 471.2 for akemisaponins E, 1089.7 --> 601.1 for saponin PJ(1) , 957.6 --> 487.4 for Scheffoleoside A and 799.5 --> 637.3 for ginsenoside Rg(1) (Rg(1) , internal standard). Method validation parameters (calibration curve linearity, lower limit of detection, recovery, matrix effect, intra- and inter-day precision) were within the acceptable ranges. This is the first reported on the UHPLC-MS/MS detection of saponin PH, akemisaponins E, saponin PJ(1) and Scheffoleoside A, and applied to a preclinical pharmacokinetic study after oral administration of A. trifoliata extract in rats. This study provides a basis for clinical application and further development of A. trifoliata extract.